Fertility and sterility | 2019

Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model.

 
 
 
 
 
 
 

Abstract


OBJECTIVE\nTo study the effects of short- and long-term vitamin D treatment on uterine leiomyomas in\xa0vivo through cell proliferation, extracellular matrix (ECM) degradation, and apoptosis.\n\n\nDESIGN\nPreclinical study of human leiomyoma treatment with vitamin D in an nonhuman animal model.\n\n\nSETTING\nHospital and university laboratories.\n\n\nPATIENT(S)/ANIMAL(S)\nHuman leiomyomas were collected from patients and implanted in ovariectomized NOD-SCID mice.\n\n\nINTERVENTION(S)\nMice were treated with vitamin D (0.5 μg/kg/d or 1 μg/kg/d) or vehicle for 21 or 60 days.\n\n\nMAIN OUTCOME MEASURE(S)\nVitamin D effect in xenograft tissue was assessed by monitoring tumor size (18F-FDG positron-emission tomography/computerized tomography and macroscopic examination), cell proliferation (immunohistochemistry and quantitative real-time polymerase chain reaction [qRT-PCR]), ECM (Western blot), transforming growth factor (TGF) β3 (qRT-PCR), and apoptosis (Westrn blot and TUNEL).\n\n\nRESULT(S)\nShort-term treatment with vitamin D did not appear to alter leiomyoma size, based on in\xa0vivo monitoring and macroscopic examination. However, long-term high-dose treatment induced a significant reduction in leiomyoma size. Cell proliferation was not decreased in the short term, whereas 1 μg/kg/d vitamin D in the long term significantly reduced proliferation compared with control. Although collagen-I and plasminogen activator inhibitor 1 were not modified by short-term treatment, they were both significantly reduced by long-term high-dose vitamin D. Similarly, long-term high-dose vitamin D significantly reduced TGF-β3 expression. Finally, apoptosis significantly increased with both short- and long-term high-dose vitamin D treatment.\n\n\nCONCLUSION(S)\nLong-term vitamin D acts as an antiproliferative, antifibrotic, and proapoptotic therapy that provides a safe, nonsurgical therapeutic option for reducing uterine leiomyoma size without side-effects.

Volume None
Pages None
DOI 10.1016/j.fertnstert.2019.09.018
Language English
Journal Fertility and sterility

Full Text